SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-004041
Filing Date
2018-03-28
Accepted
2018-03-28 16:47:30
Documents
70
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1431415
2 ex21-1.htm EX-21.1 5842
3 ex23-1.htm EX-23.1 4218
4 ex31-1.htm EX-31.1 18345
5 ex31-2.htm EX-31.2 18208
6 ex32-1.htm EX-32.1 8938
7 ex32-2.htm EX-32.2 8419
  Complete submission text file 0001493152-18-004041.txt   5728484

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE prph-20171231.xml EX-101.INS 905602
9 XBRL SCHEMA FILE prph-20171231.xsd EX-101.SCH 64825
10 XBRL CALCULATION FILE prph-20171231_cal.xml EX-101.CAL 81632
11 XBRL DEFINITION FILE prph-20171231_def.xml EX-101.DEF 221110
12 XBRL LABEL FILE prph-20171231_lab.xml EX-101.LAB 474398
13 XBRL PRESENTATION FILE prph-20171231_pre.xml EX-101.PRE 338124
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 18719432
SIC: 2834 Pharmaceutical Preparations